Global Glabridin Market Strategic Research Report

Scope of the Report

The global Glabridin market size is predicted to grow from US$ 41.11 million in 2025 to US$ 64.32 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Glabridin is a naturally occurring flavonoid primarily extracted from the roots of Glycyrrhiza glabra (licorice). Renowned for its potent antioxidant and anti-inflammatory properties, glabridin is often incorporated into cosmetic formulations and skincare products to help brighten skin tone, reduce hyperpigmentation, and protect against oxidative stress. Beyond its dermatological benefits, ongoing research also investigates glabridin’s potential roles in metabolic health and inflammation management. Its efficacy and versatility, coupled with a relatively limited global supply, make glabridin a high-value active ingredient in both the personal care and nutraceutical industries.

The global Glabridin market shows a strong presence in Asia-Pacific, particularly driven by the high demand for skin-whitening products in countries such as China, South Korea, and Japan. In these markets, consumers prioritize natural and plant-derived actives, making Glabridin an attractive ingredient. Europe and North America also demonstrate steady growth, supported by a rising trend toward clean-label cosmetics and heightened awareness of the potential benefits of licorice root extracts. Meanwhile, emerging markets in Latin America and the Middle East are gradually embracing Glabridin-based formulations as consumer preferences shift toward safe and effective natural solutions.

Leading companies in the Glabridin sector include specialized botanical extract manufacturers and major cosmetic ingredient suppliers. These enterprises often invest heavily in research and development to refine extraction technologies—such as supercritical CO₂—and ensure high purity and consistent active content. Smaller, niche players also operate in the market, focusing on cost-effective or custom-formulated Glabridin extracts for targeted applications. Overall competition is shaped by product quality, supply-chain reliability, and brand recognition, with top manufacturers securing partnerships with global cosmetic brands seeking proven whitening and antioxidant solutions. The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.

This report presents a comprehensive overview of the global Glabridin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Up to 20% (HPLC)
• 40% (HPLC)
• 60% (HPLC)
• 90% (HPLC)
• 98% (HPLC)

Segment by Application

• Creams and Lotions
• Masks
• Sunscreen Products
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Glabridin market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Creams and Lotions, Masks, Sunscreen Products evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact